Michael R. Hayden

Insider Reports History

Entity
Individual
Location
C/O Aspreva Pharmaceuticals Corporation, 1203 4464 Markham Street, Victoria, British Columbia, Canada
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Michael R. Hayden
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael R. Hayden:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AbCellera Biologics Inc. Director Common Shares 1.32M $3.57M $2.70 Sep 22, 2023 Indirect
IONIS PHARMACEUTICALS INC Director Common Stock 30.2K $1.52M $50.42 Jul 17, 2023 Direct
Xenon Pharmaceuticals Inc. Director Common Shares 116K $1.14M $9.85 May 18, 2021 Direct
Xenon Pharmaceuticals Inc. Director Common Shares 114K $1.13M $9.85 May 18, 2021 By wife
89bio, Inc. Director Common Stock 80.9K $933K $11.53 Mar 30, 2022 Direct
Xenon Pharmaceuticals Inc. Director Common Shares 92.1K $907K $9.85 May 18, 2021 By Genworks Inc.
89bio, Inc. Director Common Stock 61.5K $710K $11.53 Mar 28, 2023 Indirect
IONIS PHARMACEUTICALS INC Director Restricted Stock Unit 8.76K $353K $40.29 Jul 1, 2024 Direct
AbCellera Biologics Inc. Director Common Shares 118K $319K $2.70 Sep 22, 2023 By spouse
IONIS PHARMACEUTICALS INC Director Common Stock 2K $101K $50.42 Jul 17, 2023 by Spouse
AbCellera Biologics Inc. Director Share option (right to buy) 661K Jun 21, 2024 Direct
89bio, Inc. Director Stock Option (Right to Buy) 45.2K Feb 1, 2024 Direct
IONIS PHARMACEUTICALS INC Director Non-Qualified Stock Option (right to buy) 10.1K Jul 1, 2024 Direct
Xenon Pharmaceuticals Inc. Director Stock Option (Right to Buy) 10K Jun 3, 2021 Direct

Insider Reports Filed by Michael R. Hayden

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IONS IONIS PHARMACEUTICALS INC Jul 1, 2024 2 $0 4 Jul 3, 2024 Director
ABCL AbCellera Biologics Inc. Jun 21, 2024 1 $0 4 Jun 24, 2024 Director
ETNB 89bio, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 Director
ABCL AbCellera Biologics Inc. Sep 22, 2023 1 $98.2K 4 Sep 26, 2023 Director
ABCL AbCellera Biologics Inc. Aug 8, 2023 1 $177K 4 Aug 9, 2023 Director
IONS IONIS PHARMACEUTICALS INC Jul 17, 2023 4 $0 4 Jul 19, 2023 Director
IONS IONIS PHARMACEUTICALS INC Jul 3, 2023 2 $0 4 Jul 6, 2023 Director
ETNB 89bio, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director
IONS IONIS PHARMACEUTICALS INC Dec 31, 2022 0 $0 5 Feb 14, 2023 Director
ABCL AbCellera Biologics Inc. Dec 1, 2022 1 $0 4 Dec 5, 2022 Director
IONS IONIS PHARMACEUTICALS INC Oct 17, 2022 2 $0 4 Oct 18, 2022 Director
IONS IONIS PHARMACEUTICALS INC Jul 15, 2022 4 $0 4 Jul 19, 2022 Director
IONS IONIS PHARMACEUTICALS INC Jul 1, 2022 2 $0 4 Jul 6, 2022 Director
ETNB 89bio, Inc. May 16, 2022 1 $0 4 May 18, 2022 Director
ETNB 89bio, Inc. Mar 30, 2022 4 $1.08M 4 Mar 30, 2023 Director
ABCL AbCellera Biologics Inc. Dec 7, 2021 2 $0 4 Dec 10, 2021 Director
IONS IONIS PHARMACEUTICALS INC Oct 15, 2021 2 $0 4 Oct 19, 2021 Director
ABCL AbCellera Biologics Inc. Sep 13, 2021 2 $4.79M 4 Sep 15, 2021 Director
IONS IONIS PHARMACEUTICALS INC Jul 15, 2021 4 $0 4 Jul 19, 2021 Director
IONS IONIS PHARMACEUTICALS INC Jul 1, 2021 2 $0 4 Jul 6, 2021 Director
ABCL AbCellera Biologics Inc. Jun 22, 2021 1 -$2.55M 4 Jun 22, 2021 Director
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 1 $0 4 Jun 3, 2021 Director
XENE Xenon Pharmaceuticals Inc. May 18, 2021 2 $13.5K 4 May 20, 2021 Director